Abstract

The management of asthma can be significantly impacted by anxiety and depression. The purpose of the study was to examine potential risk factors and treatment options while evaluating the psychosocial effects of asthma patients during COVID-19. The "Questionnaire Star" computerised questionnaire system was used to gather information in June 2022. The questionnaires were given to a total of 98 asthma patients from the Ningbo University Medical School's affiliated hospital. Our study found that the prevalence of anxiety and depression symptoms among asthma patients in the facility was 91.8 and 77.6%, respectively. Those who did not take part in asthma day activities were more likely to develop anxiety symptoms than patients who had an asthma exacerbation in the previous two months. According to this study, regular disease-education lectures held on World Asthma Day can significantly reduce the anxiety and depression experienced by asthma patients.